"10.1371_journal.pone.0006501","plos one","2009-08-07T00:00:00Z","Steven G Potkin; Guia Guffanti; Anita Lakatos; Jessica A Turner; Frithjof Kruggel; James H Fallon; Andrew J Saykin; Alessandro Orro; Sara Lupoli; Erika Salvi; Michael Weiner; Fabio Macciardi; for the Alzheimer's Disease Neuroimaging Initiative","Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, California, United States of America; Department of Sciences and Biomedical Technologies, University of Milan, Segrate (MI), Italy; Department of Biomedical Engineering, University of California Irvine, Irvine, California, United States of America; Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Segrate (MI), Italy; Universita Vita e Salute, Department of Neurology and Neuroscience, Milan, Italy; Department of Radiology, Psychiatry and Neurology, University of California San Francisco, San Francisco, California, United States of America","Conceived and designed the experiments: SGP AS MW. Analyzed the data: GG AL JT FK JF SL ES FM. Contributed reagents/materials/analysis tools: AO. Wrote the paper: SGP GG AL JT FK JF FM.","Dr. Potkin has read the journals policy and declares the following competing interest: Dr. Potkin has received funding for this project from NIAAA and NIBIB, Vanda Pharmaceuticals and an anonymous foundation. Dr. Potkin has received grant support or has been a consultant to several companies that have contributed to the NIH Foundation that has provided some financial support for the ADNI study including Pfizer Inc., Wyeth Research, Bristol-Myers Squibb, Eli Lilly and Company, Merck & Co. Inc., AstraZeneca AB, Novartis Pharmaceuticals Corporation, Alzheimers Association, Elan Corporation plc, and Forest Laboratories.","2009","08","Steven G Potkin","SGP",13,TRUE,3,NA,8,7,TRUE,FALSE,TRUE,1,"13",TRUE
